Literature DB >> 7887154

The effect of panretinal laser photocoagulation on visual acuity, visual fields and on subjective visual impairment in preproliferative and early proliferative diabetic retinopathy.

M Henricsson1, A Heijl.   

Abstract

The effect of panretinal laser scatter treatment on visual fields, visual acuity and subjective complaints was assessed in 11 patients with severe nonproliferative or early proliferative diabetic retinopathy. Patients were prospectively examined before and after panretinal treatment using automated static threshold perimetry with program 30-2 on the Humphrey perimeter, and they were interviewed. Visual field sensitivity was often depressed even before treatment with mean MD -4.3 (-1, -11.6) dB, but was significantly lower (p < 0.01, ANOVA) 2 weeks after treatment with mean MD -8.6 dB. Visual fields remained stable 4 months later. Treatment increased the number of eyes with visual fields as defined by abnormal MD values at the p < 0.05 level from 8 to 16 among the 17 treated. In spite of considerable impairment of visual fields after treatment, subjective problems were small and the visual field impairment seemed to have little influence on everyday life.

Entities:  

Mesh:

Year:  1994        PMID: 7887154     DOI: 10.1111/j.1755-3768.1994.tb07181.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  16 in total

1.  Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation.

Authors:  D Pahor
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

Review 2.  Ultra widefield fundus imaging for diabetic retinopathy.

Authors:  Szilárd Kiss; Thomas L Berenberg
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

3.  Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy.

Authors:  Ahmad Mirshahi; Alireza Lashay; Mehdi Roozbahani; Masoud Aghsaei Fard; Saber Molaie; Meysam Mireshghi; Mohamad Mehdi Zaferani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-11       Impact factor: 3.117

4.  Macular function assessed with mfERG before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.

Authors:  Monica Lövestam-Adrian; Sten Andréasson; Vesna Ponjavic
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

5.  Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.

Authors:  Masahiko Shimura; Toru Nakazawa; Kanako Yasuda; Takashi Shiono; Kohji Nishida
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

Review 6.  Evaluation of Laser Effects on the Human Body After Laser Therapy.

Authors:  Ensieh Khalkhal; Mohammadreza Razzaghi; Mohammad Rostami-Nejad; Majid Rezaei-Tavirani; Hazhir Heidari Beigvand; Mostafa Rezaei Tavirani
Journal:  J Lasers Med Sci       Date:  2020-01-18

7.  Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy.

Authors:  Masahiko Shimura; Kanako Yasuda; Toru Nakazawa; Toshiaki Abe; Takashi Shiono; Tomohiro Iida; Taiji Sakamoto; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-29       Impact factor: 3.117

8.  Retinal function and PKC alpha expression after focal laser photocoagulation.

Authors:  Karin Gjörloff Wallentén; Malin Malmsjö; Sten Andréasson; Angelica Wackenfors; Kristina Johansson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-17       Impact factor: 3.117

9.  Comparison of pre-retinal oxygen pressure changes after selective retina therapy versus conventional photocoagulation in the rabbit eye.

Authors:  Jae Ryun Kim; Young-Gun Park; Young Jung Roh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-02       Impact factor: 3.117

10.  Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.

Authors:  Katharina Messias; Rafael de Montier Barroso; Rodrigo Jorge; Andre Messias
Journal:  Doc Ophthalmol       Date:  2018-09-12       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.